Résultats de la recherche - 6 results
Airtightness in Belgian high biocontainment facilities
of Contained Use & Deliberate release of GMO s (EEP2011) about the current situation on airtightness in highcontainment facilities throughout Europe, the Biosafety and Biotechnology Unit (SBB) of ...
Laboratory-acquired infections in Belgium (2007-2012): an online survey
for Care and Health, Public Health Surveillance, the Biosafety and Biotechnology Unit (SBB), which belongs to the Scientific Institute of Public Health, developed asurvey in the interest of mapping and ...
Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 14581
ON Paper recombinant vector recombination REVIEW risk Risk Assessment risks SAFETY SBB Smallpox specific strain System Therapy Transgene Type use Vaccination vaccine Vaccinia vaccinia virus Vector ...
Event report: SynBio Workshop (Paris 2012)- Risk assessment challenges of Synthetic Biology
Netherlands New techniques ON public public health Public-health questions Regulatory report Research REVIEW risk Risk Assessment SAFETY SBB Synthetic Synthetic Biology The Netherlands Abstract: In Europe and ...
Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges
Regulatory REVIEW SAFETY SBB Synthetic Synthetic Biology Technique website Abstract: This document is a background paper aiming at providing general information and considerations about techniques, ...
Biosafety in laboratory animal facilities
management measure measures Notification ON Order Paper pathogen Practice PRACTICES protection public public health Public-health Quality regional regulation SBB Transgenic use Waste website welfare Abstract: ...